Literature DB >> 19850833

Identification of barriers to retinal engraftment of transplanted stem cells.

Thomas V Johnson1, Natalie D Bull, Keith R Martin.   

Abstract

PURPOSE: Intraocular stem cell transplantation may be therapeutic for retinal neurodegenerative diseases such as glaucoma via neuronal replacement and/or neuroprotection. However, efficacy is hindered by extremely poor retinal graft integration. The purpose was to identify the major barrier to retinal integration of intravitreally transplanted stem cells, which was hypothesized to include the cellular and/or extracellular matrix (ECM) components of the inner limiting membrane (ILM).
METHODS: Mesenchymal stem cells (MSCs) were cocultured on the vitreal surface of retinal explants. Retinal MSC migration was compared between control explants and explants in which portions of the ILM were removed by mechanical peeling; the inner basal lamina was digested with collagenase; and glial cell reactivity was selectively modulated with alpha-aminoadipic acid (AAA). In vivo, the MSCs were transplanted after intravitreal AAA or saline injection into glaucomatous rat eyes.
RESULTS: Retinal MSC migration correlated positively with the amount of peeled ILM, whereas enzymatic digestion of the basal lamina was robust but did not enhance MSC entry. In contrast, AAA treatment suppressed glial cell reactivity and facilitated a >50-fold increase in MSC migration into retinal explants. In vivo analysis showed that AAA treatment led to a more than fourfold increase in retinal engraftment.
CONCLUSIONS: The results demonstrated that the ECM of the inner basal lamina is neither necessary nor sufficient to prevent migration of transplanted cells into the neural retina. In contrast, glial reactivity was associated with poor graft migration. Targeted disruption of glial reactivity dramatically improved the structural integration of intravitreally transplanted cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19850833      PMCID: PMC2868445          DOI: 10.1167/iovs.09-3884

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  53 in total

1.  Incorporation and differentiation of hippocampus-derived neural stem cells transplanted in injured adult rat retina.

Authors:  A Nishida; M Takahashi; H Tanihara; I Nakano; J B Takahashi; A Mizoguchi; C Ide; Y Honda
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-12       Impact factor: 4.799

Review 2.  Transplantation prospects for the inner retina.

Authors:  T V Johnson; N D Bull; K R Martin
Journal:  Eye (Lond)       Date:  2008-12-19       Impact factor: 3.775

3.  Effects of direct transplantation of multipotent mesenchymal stromal/stem cells into the demyelinated spinal cord.

Authors:  D P J Hunt; K A Irvine; D J Webber; D A S Compston; W F Blakemore; S Chandran
Journal:  Cell Transplant       Date:  2008       Impact factor: 4.064

Review 4.  Mesenchymal stem cell homing: the devil is in the details.

Authors:  Jeffrey M Karp; Grace Sock Leng Teo
Journal:  Cell Stem Cell       Date:  2009-03-06       Impact factor: 24.633

5.  Stem cells for neuroprotection in glaucoma.

Authors:  N D Bull; T V Johnson; K R Martin
Journal:  Prog Brain Res       Date:  2008       Impact factor: 2.453

6.  Development and characterization of an adult retinal explant organotypic tissue culture system as an in vitro intraocular stem cell transplantation model.

Authors:  Thomas V Johnson; Keith R Martin
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-04-11       Impact factor: 4.799

7.  GFAP null astrocytes are a favorable substrate for neuronal survival and neurite growth.

Authors:  V Menet; M Giménez Y Ribotta; F Sandillon; A Privat
Journal:  Glia       Date:  2000-09       Impact factor: 7.452

8.  Effects of bone-marrow mesenchymal stem cells transplanted into vitreous cavity of rat injured by ischemia/reperfusion.

Authors:  Na Li; Xiao-rong Li; Jia-qin Yuan
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-12-16       Impact factor: 3.117

9.  Engrafted chicken neural tube-derived stem cells support the innate propensity for axonal regeneration within the rat optic nerve.

Authors:  Petar Charalambous; Louise A Hurst; Solon Thanos
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-04-11       Impact factor: 4.799

10.  Transplantation of human embryonic stem cell-derived photoreceptors restores some visual function in Crx-deficient mice.

Authors:  Deepak A Lamba; Juliane Gust; Thomas A Reh
Journal:  Cell Stem Cell       Date:  2009-01-09       Impact factor: 24.633

View more
  46 in total

1.  A Self-Assembling Injectable Biomimetic Microenvironment Encourages Retinal Ganglion Cell Axon Extension in Vitro.

Authors:  Melissa R Laughter; David A Ammar; James R Bardill; Brisa Pena; Malik Y Kahook; David J Lee; Daewon Park
Journal:  ACS Appl Mater Interfaces       Date:  2016-08-02       Impact factor: 9.229

2.  Use of an adult rat retinal explant model for screening of potential retinal ganglion cell neuroprotective therapies.

Authors:  Natalie D Bull; Thomas V Johnson; Guncha Welsapar; Nicholas W DeKorver; Stanislav I Tomarev; Keith R Martin
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-05-17       Impact factor: 4.799

Review 3.  Mobilizing endogenous stem cells for retinal repair.

Authors:  Honghua Yu; Thi Hong Khanh Vu; Kin-Sang Cho; Chenying Guo; Dong Feng Chen
Journal:  Transl Res       Date:  2013-11-22       Impact factor: 7.012

4.  Bone-marrow mesenchymal stem-cell administration significantly improves outcome after retinal ischemia in rats.

Authors:  Biji Mathew; Jacqueline N Poston; John C Dreixler; Leianne Torres; Jasmine Lopez; Ruth Zelkha; Irina Balyasnikova; Maciej S Lesniak; Steven Roth
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-05-18       Impact factor: 3.117

5.  Stem cell therapy for glaucoma: possibilities and practicalities.

Authors:  Thomas V Johnson; Natalie D Bull; Keith R Martin
Journal:  Expert Rev Ophthalmol       Date:  2011-04-01

6.  Mesenchymal stem cell-derived extracellular vesicles and retinal ischemia-reperfusion.

Authors:  Biji Mathew; Sriram Ravindran; Xiaorong Liu; Leianne Torres; Mohansrinivas Chennakesavalu; Chun-Chieh Huang; Liang Feng; Ruth Zelka; Jasmine Lopez; Monica Sharma; Steven Roth
Journal:  Biomaterials       Date:  2019-01-09       Impact factor: 12.479

Review 7.  Neuro-protection and neuro-regeneration of the optic nerve: recent advances and future directions.

Authors:  Kimberly K Gokoffski; Micalla Peng; Basheer Alas; Phillip Lam
Journal:  Curr Opin Neurol       Date:  2020-02       Impact factor: 5.710

8.  Scaffolds and stem cells: delivery of cell transplants for retinal degenerations.

Authors:  Karl E Kador; Jeffrey L Goldberg
Journal:  Expert Rev Ophthalmol       Date:  2012-10-01

9.  Progranulin, a major secreted protein of mouse adipose-derived stem cells, inhibits light-induced retinal degeneration.

Authors:  Kazuhiro Tsuruma; Mika Yamauchi; Sou Sugitani; Tomohiro Otsuka; Yuta Ohno; Yuki Nagahara; Yuka Ikegame; Masamitsu Shimazawa; Shinichi Yoshimura; Toru Iwama; Hideaki Hara
Journal:  Stem Cells Transl Med       Date:  2013-11-14       Impact factor: 6.940

10.  In vitro formation of neuroclusters in microfluidic devices and cell migration as a function of stromal-derived growth factor 1 gradients.

Authors:  Sean McCutcheon; Uchenna Unachukwu; Ankush Thakur; Robert Majeska; Stephen Redenti; Maribel Vazquez
Journal:  Cell Adh Migr       Date:  2016-01-08       Impact factor: 3.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.